Skip to content
DraconiticResearch
Search Sources API
182,544 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BYHeartRhythm case reports

How to individualize device therapy in transthyretin cardiac amyloidosis: A dyssynchrony-based case report.

  1. 1Department of Cardiology, Necmettin Erbakan University, School of Medicine, Konya, Türkiye.

Related

  1. One-minute heart rate recovery and clinical outcomes in transthyretin cardiac amyloidosis: incremental model fit beyond conventional CPET indices
    European heart journal openPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  2. Closing the diagnostic gap in transthyretin cardiac amyloidosis: red flags, modern imaging, and emerging therapies
    Zhengjun Yi, Peng Li, Xueqian Wang
    Frontiers in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  3. Delayed Diagnosis of Hereditary Transthyretin Cardiac Amyloidosis Presenting with Autonomic Neuropathy: A Case Report
    Bingjie Song, Qijun Zhang, Lei Tao +2
    Journal of cardiovascular development and diseasePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. Demographic Representation in Clinical Trials for Transthyretin-Associated Cardiac Amyloidosis: A Systematic Review
    Dimitri Ford, Chima Amadi, Akshay Chandora +6
    Reviews in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. Survival Outcomes in Transthyretin Cardiac Amyloidosis in the Tafamidis Era: Real-World Evidence from Greece
    Freideriki Eleni Kourti, Alexios S. Antonopoulos, Vasileios Kytinos +14
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{sahin2026individualize,
  title = {{How to individualize device therapy in transthyretin cardiac amyloidosis: A dyssynchrony-based case report.}},
  author = {Ahmet Taha Sahin and Ahmet Lutfu Sertdemir and Yakup Alsancak and Mustafa Celik and Enes Elvin Gul},
  journal = {HeartRhythm case reports},
  year = {2026},
  month = jul,
  doi = {10.1016/j.hrcr.2026.07.015},
  url = {https://europepmc.org/article/MED/42923210},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - How to individualize device therapy in transthyretin cardiac amyloidosis: A dyssynchrony-based case report.
AU  - Ahmet Taha Sahin
AU  - Ahmet Lutfu Sertdemir
AU  - Yakup Alsancak
AU  - Mustafa Celik
AU  - Enes Elvin Gul
PY  - 2026
DA  - 2026/07/29
JO  - HeartRhythm case reports
DO  - 10.1016/j.hrcr.2026.07.015
UR  - https://europepmc.org/article/MED/42923210
SN  - 2214-0271
ER  -